NCT00510016View on ClinicalTrials.gov

Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2002

Study Completion Date

December 31, 2005

Conditions
Neonatal Abstinence Syndrome
Interventions
DRUG

Clonidine HCL

Duraclon 1 microgram/kg every 4 hours given p.o. as per algorithm

Trial Locations (1)

21287-3200

Johns Hopkins Medical Institutions, Baltimore

All Listed Sponsors
collaborator

Johns Hopkins University

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00510016 - Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome | Biotech Hunter | Biotech Hunter